Publication | Closed Access
Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery
218
Citations
37
References
2005
Year
In patients undergoing major abdominal surgery, alvimopan accelerated gastrointestinal recovery and time to the hospital discharge order written compared with placebo and was well tolerated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1